囊对Streptococcus pneumoniae的自然转化具有抑制作用
bioRxiv : the preprint server for biology
|July 14, 2025
概括
肺炎链球菌 (Spn) 的囊通过干扰复合体来阻碍自然的转化. 囊的存在和类型显著降低了Spn转换频率.
科学领域:
- 微生物学 微生物学
- 细菌遗传学 细菌遗传学
- 分子生物学分子生物学
背景情况:
- 肺炎链球菌 (Spn) 囊是一种关键的毒性因子,具有100多种血清型.
- 在 Spn 中的自然转化主要研究在未封装的菌株中,但临床分离物显示出不同的转化速率.
- 在封装的Spn中,囊和转化效率之间的关系尚不清楚.
研究的目的:
- 调查SPN囊类型和数量的直接影响自然转化效率.
- 阐明囊影响转变的机制.
- 挑战这样一个范式,即未封装的菌株完全代表了Spn转换动态.
主要方法:
- 在同源 Spn 囊切换菌株中转化频率的比较.
- 使用一个GFP-reporter来监测Com regulon基因表达.
- 使用抗体结合 (ComGC) 和电子显微镜评估了Compilus表面暴露.
- 检查了囊的多孔性.
主要成果:
- 在不同的囊类型和数量中,转化频率差异很大,而未封装的菌株的转化率更高.
- 囊的存在和依赖于血清型的因素抑制了Compilus的组装和功能.
- 更高的转换频率与更多孔的囊和更大的Compilus表面暴露相关.
- 与封装菌株相比,未封装菌株表现出较长的皮质.
结论:
- 该SPN囊直接通过干扰Compilus组装和功能来抑制自然转化.
- 囊作为一个多功能调节器,平衡Spn毒性和适应性.
- 这些发现有助于更好地了解肺炎球菌的进化和囊的作用,而不仅仅是屏蔽.
相关概念视频
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...


